Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate

Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate

Show other versions (1)

Zuclopenthixol is available in two parenteral formulation,i.e., in the form of acetate and decanoate. It has high affinity for dopamine D1 and D2 receptors. There is limited literature of association of neuroleptic malignant syndrome with the use of zuclopenthixol monotherapy. These case reports hav...

Full description

Bibliographic Details
Main Authors: Anish Shouan, Ankit Kumar Sinha, Sandeep Grover
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Industrial Psychiatry Journal
Subjects:
neuroleptic malignant syndrome
side effect
zuclopenthixol
Online Access:http://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2020;volume=29;issue=1;spage=162;epage=164;aulast=Shouan

Internet

http://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2020;volume=29;issue=1;spage=162;epage=164;aulast=Shouan

Similar Items